{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:53:50Z","timestamp":1787889230447,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-022-01960-1","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T05:11:31Z","timestamp":1669612291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence"],"prefix":"10.1007","volume":"18","author":[{"given":"Rosaria","family":"Cozzolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"De Giulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Martignetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Ventriglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stocchero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"4","key":"1960_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/01480545.2014.974265","volume":"38","author":"AO Abolaji","year":"2015","unstructured":"Abolaji, A. O., Adedara, I. A., Soladogun, A., Salau, V., Oguaka, M., & Farombi, E. O. (2015). Exposure to 2,5-hexanedione is accompanied by ovarian and uterine oxidative stress and disruption of endocrine balance in rats. Drug and Chemical Toxicology, 38(4), 400\u2013407. https:\/\/doi.org\/10.3109\/01480545.2014.974265.","journal-title":"Drug and Chemical Toxicology"},{"issue":"2","key":"1960_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15403\/jgld.2014.1121.242.ury","volume":"24","author":"RP Arasaradnam","year":"2015","unstructured":"Arasaradnam, R. P., McFarlane, M., Daulton, E., Westenbrink, E., O\u2019Connell, N., Wurie, S., Nwokolo, C. U., Bardhan, K. D., Savage, R. S., & Covington, J. A. (2015). Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results. Journal of Gastrointestinal and Liver Diseases, 24(2), 197\u2013201. https:\/\/doi.org\/10.15403\/jgld.2014.1121.242.ury.","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"9","key":"1960_CR3","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/molecules26092447","volume":"22","author":"AS Bannaga","year":"2021","unstructured":"Bannaga, A. S., Tyagi, H., Daulton, E., Covington, J. A., & Arasaradnam, R. P. (2021). Exploratory study using urinary volatile Organic Compounds for the detection of Hepatocellular Carcinoma. Molecules, 22(9), 2447. https:\/\/doi.org\/10.3390\/molecules26092447.","journal-title":"Molecules"},{"issue":"1","key":"1960_CR4","doi-asserted-by":"publisher","first-page":"e001575","DOI":"10.1136\/bmjdrc-2020-001575","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X., Liu, W., Wang, L., Lin, D., Nie, L., He, K., Guo, Z., Zhu, F., Feng, W., Liu, W., Yuan, J., Yang, X., Spencer, P., & Liu, J. (2020). Diabetes mellitus is associated with elevated urinary pyrrole markers of \u03b3-diketones known to cause axonal neuropathy. BMJ Open Diabetes Research & Care, 8(1), e001575. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001575.","journal-title":"BMJ Open Diabetes Research & Care"},{"key":"1960_CR5","doi-asserted-by":"publisher","first-page":"15636","DOI":"10.1038\/s41598-017-15957-7","volume":"7","author":"R Cozzolino","year":"2017","unstructured":"Cozzolino, R., De Giulio, B., Marena, P., Martignetti, A., G\u00fcnther, K., Lauria, F., Russo, P., Stocchero, M., & Siani, A. (2017). Urinary volatile organic compounds in overweight compared to normal-weight children: results from the italian I.Family cohort. Scientific Reports, 7, 15636. https:\/\/doi.org\/10.1038\/s41598-017-15957-7.","journal-title":"Scientific Reports"},{"issue":"3","key":"1960_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.15403\/jgld.2014.1121.263","volume":"26","author":"M Dallio","year":"2017","unstructured":"Dallio, M., Masarone, M., Caprio, G. G., Di Sarno, R., Tuccillo, C., Sasso, F. C., Persico, M., Loguercio, C., & Federico, A. (2017). Endocan serum levels in patients with non-alcoholic fatty liver disease with or without type 2 diabetes Mellitus: a pilot study. Journal of Gastrointestinal and Liver Diseases, 26(3), 261\u2013268. https:\/\/doi.org\/10.15403\/jgld.2014.1121.263.","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"5","key":"1960_CR7","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3390\/nu13051679","volume":"15","author":"M Dallio","year":"2021","unstructured":"Dallio, M., Romeo, M., Gravina, A. G., Masarone, M., Larussa, T., Abenavoli, L., Persico, M., Loguercio, C., & Federico, A. (2021a). Nutrigenomics and nutrigenetics in metabolic- (dysfunction) associated fatty liver disease: novel insights and future perspectives. Nutrients, 15(5), 1679. https:\/\/doi.org\/10.3390\/nu13051679.","journal-title":"Nutrients"},{"issue":"1","key":"1960_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ijms22010436","volume":"4","author":"M Dallio","year":"2021","unstructured":"Dallio, M., Sangineto, M., Romeo, M., Villani, R., Romano, A. D., Loguercio, C., Serviddio, G., & Federico, A. (2021b). Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression. International Journal of Molecular Sciences, 4(1), 436. https:\/\/doi.org\/10.3390\/ijms22010436.","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"1960_CR9","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J., & George, J. (2020). International Consensus Panel. MAFLD: A consensus-driven proposed nomenclature for metabolic Associated fatty liver disease. Gastroenterology, 158(7), 1999\u20132014e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312.","journal-title":"Gastroenterology"},{"issue":"6","key":"1960_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/gtc.12237","volume":"20","author":"M Goto","year":"2015","unstructured":"Goto, M., Kitamura, H., Alam, M. M., Ota, N., Haseba, T., Akimoto, T., Shimizu, A., Takano-Yamamoto, T., Yamamoto, M., & Motohashi, H. (2015). Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis. Genes to Cells, 20(6), 464\u2013480. https:\/\/doi.org\/10.1111\/gtc.12237.","journal-title":"Genes to Cells"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.intimp.2016.01.024","volume":"33","author":"VS Honmore","year":"2016","unstructured":"Honmore, V. S., Kandhare, A. D., Kadam, P. P., Khedkar, V. M., Sarkar, D., Bodhankar, S. L., Zanwar, A. A., Rojatkar, S. R., & Natu, A. D. (2016). Isolates of Alpinia officinarum Hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies. International Immunopharmacology, 33, 8\u201317. https:\/\/doi.org\/10.1016\/j.intimp.2016.01.024.","journal-title":"International Immunopharmacology"},{"key":"1960_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.freeradbiomed.2020.11.013","volume":"162","author":"R Huang","year":"2021","unstructured":"Huang, R., Hou, L., Zhai, X., Ruan, Z., Sun, W., Zhang, D., Zhao, X., & Wang, Q. (2021). 2,5-hexanedione induces NLRP3 inflammasome activation and neurotoxicity through NADPH oxidase-dependent pathway. Free Radical Biology & Medicine, 162, 561\u2013570. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.11.013.","journal-title":"Free Radical Biology & Medicine"},{"key":"1960_CR13","volume-title":"Principal component analysis","author":"IT Jolliffe","year":"2002","unstructured":"Jolliffe, I. T. (2002). Principal component analysis (2nd ed.). New York: Springer-Verlag. Springer Series in Statistics.","edition":"2"},{"key":"1960_CR14","unstructured":"K\u00e4r\u00e4j\u00e4m\u00e4ki, A. (2017). Non-alcoholic fatty liver disease (NAFLD): perspectives to etiology, complications and lipid metabolism. Acta Universitatis Ouluensis D Medica 1438. Retrieved January 7, 2022. http:\/\/jultika.oulu.fi\/files\/isbn9789526217376.pdf."},{"key":"1960_CR15","doi-asserted-by":"publisher","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","volume":"12","author":"T Kessoku","year":"2021","unstructured":"Kessoku, T., Kobayashi, T., Imajo, K., Tanaka, K., Yamamoto, A., Takahashi, K., Kasai, Y., Ozaki, A., Iwaki, M., Nogami, A., Honda, Y., Ogawa, Y., Kato, S., Higurashi, T., Hosono, K., Yoneda, M., Okamoto, T., Usuda, H., & Nakajima, A. (2021). Endotoxins and non-alcoholic fatty liver disease. Frontiers in Endocrinology, 12, 770986. https:\/\/doi.org\/10.3389\/fendo.2021.770986.","journal-title":"Frontiers in Endocrinology"},{"issue":"4","key":"1960_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.dld.2017.12.018","volume":"50","author":"SS Kim","year":"2018","unstructured":"Kim, S. S., Cho, H. J., Kim, H. J., Kang, D. R., Berry, J. R., Kim, J. H., Yang, M. J., Lim, S. G., Kim, S., Cheong, J. Y., & Cho, S. W. (2018). Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. Digestive and Liver Disease, 50(4), 370\u2013377. https:\/\/doi.org\/10.1016\/j.dld.2017.12.018.","journal-title":"Digestive and Liver Disease"},{"key":"1960_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s0021-9673(00)99983-7","volume":"29","author":"HM Liebich","year":"1975","unstructured":"Liebich, H. M., & Al-Babbili, O. (1975). Gas chromatographic-mass spectrometric study of volatile organic metabolites in urines of patients with diabetes mellitus. Journal of chromatography, 29, 112:539\u2013550. https:\/\/doi.org\/10.1016\/s0021-9673(00)99983-7.","journal-title":"Journal of chromatography"},{"key":"1960_CR18","doi-asserted-by":"publisher","unstructured":"Masarone, M., Troisi, J., Aglitti, A., Torre, P., Colucci, A., Dallio, M., Federico, A., Balsano, C., & Persico, M. (2021). Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics, 6;17(2):12. https:\/\/doi.org\/10.1007\/s11306-020-01756-1.","DOI":"10.1007\/s11306-020-01756-1"},{"issue":"1","key":"1960_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2867-13-72","volume":"17","author":"P Mochalski","year":"2013","unstructured":"Mochalski, P., Sponring, A., King, J., Unterkofler, K., Troppmair, J., & Amann, A. (2013). Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro. Cancer Cell International, 17(1), 72. https:\/\/doi.org\/10.1186\/1475-2867-13-72.","journal-title":"Cancer Cell International"},{"issue":"1","key":"1960_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12967-019-02130-z","volume":"4","author":"BM Motta","year":"2019","unstructured":"Motta, B. M., Grander, C., G\u00f6gele, M., Foco, L., Vukovic, V., Melotti, R., Fuchsberger, C., De Grandi, A., Cantaloni, C., Picard, A., Mascalzoni, D., Rossini, A., Pattaro, C., Tilg, H., & Pramstaller, P. P. (2019). Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. Journal Translational Medicine, 4(1), 408. https:\/\/doi.org\/10.1186\/s12967-019-02130-z.","journal-title":"Journal Translational Medicine"},{"key":"1960_CR21","doi-asserted-by":"publisher","unstructured":"Opitz, P., & Herbarth, O. (2018). The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC). Journal of Otolaryngology - Head & Neck Surgery, 3;47(1):42. https:\/\/doi.org\/10.1186\/s40463-018-0288-5.","DOI":"10.1186\/s40463-018-0288-5"},{"key":"1960_CR22","doi-asserted-by":"publisher","first-page":"106268","DOI":"10.1016\/j.ijsu.2022.106268","volume":"99","author":"ES Pierobon","year":"2022","unstructured":"Pierobon, E. S., Capovilla, G., Moletta, L., De Pasqual, A. L., Fornasier, C., Salvador, R., Zanchettin, G., Lonardi, S., Galuppo, S., Hadzijusufovic, E., Grimminger, P. P., Stocchero, M., Costantini, M., Merigliano, S., & Valmasoni, M. (2022). Multimodal treatment of radiation-induced esophageal cancer: results of a case-matched comparative study from a single center. International Journal of Surgery, 99, 106268. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106268.","journal-title":"International Journal of Surgery"},{"issue":"3","key":"1960_CR23","first-page":"337","volume":"18","author":"CS Probert","year":"2009","unstructured":"Probert, C. S., Ahmed, I., Khalid, T., Johnson, E., Smith, S., & Ratcliffe, N. (2009). Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. Journal of Gastrointestinal and Liver Diseases, 18(3), 337\u2013343.","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"10","key":"1960_CR24","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/jm9707380","volume":"7","author":"JF Schindler","year":"1998","unstructured":"Schindler, J. F., Berst, K. B., & Plapp, B. V. (1998). Inhibition of human alcohol dehydrogenases by formamides. Journal of Medicinal Chemistry, 7(10), 1696\u20131701. https:\/\/doi.org\/10.1021\/jm9707380.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"1960_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1248\/bpb.27.138","volume":"27","author":"JE Shin","year":"2004","unstructured":"Shin, J. E., Han, M. J., Song, M. C., Baek, N. I., & Kim, D. H. (2004). 5-Hydroxy-7-(4\u2019-hydroxy-3\u2019-methoxyphenyl)-1-phenyl-3-heptanone: a pancreatic lipase inhibitor isolated from Alpinia officinarum. Biological and Pharmaceutical Bulletin, 27(1), 138\u2013140. https:\/\/doi.org\/10.1248\/bpb.27.138.","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"1960_CR26","doi-asserted-by":"publisher","first-page":"e2987","DOI":"10.1002\/cem.2987","volume":"32","author":"M Stocchero","year":"2018","unstructured":"Stocchero, M., Riccadonna, S., & Franceschi, P. (2018). Projection to latent structures with orthogonal constraints for metabolomics data. Journal of Chemometrics, 32, e2987. https:\/\/doi.org\/10.1002\/cem.2987.","journal-title":"Journal of Chemometrics"},{"key":"1960_CR27","doi-asserted-by":"publisher","first-page":"e3237","DOI":"10.1002\/cem.3237","volume":"34","author":"M Stocchero","year":"2020","unstructured":"Stocchero, M. (2020). Relevant and irrelevant predictors in PLS2. Journal of Chemometrics, 34, e3237. https:\/\/doi.org\/10.1002\/cem.3237.","journal-title":"Journal of Chemometrics"},{"issue":"1","key":"1960_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/49.1.133","volume":"49","author":"O Strubelt","year":"1999","unstructured":"Strubelt, O., Deters, M., Pentz, R., Siegers, C. P., & Younes, M. (1999). The toxic and metabolic effects of 23 aliphatic alcohols in the isolated perfused rat liver. Toxicological Sciences, 49(1), 133\u2013142. https:\/\/doi.org\/10.1093\/toxsci\/49.1.133.","journal-title":"Toxicological Sciences"},{"issue":"3","key":"1960_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.etp.2008.05.011","volume":"61","author":"R Tunca","year":"2009","unstructured":"Tunca, R., Sozmen, M., Citil, M., Karapehlivan, M., Erginsoy, S., & Yapar, K. (2009). Pyridine induction of cytochrome P450 1A1, iNOS and metallothionein in syrian hamsters and protective effects of silymarin. Experimental and Toxicologic Pathology, 61(3), 243\u2013255. https:\/\/doi.org\/10.1016\/j.etp.2008.05.011.","journal-title":"Experimental and Toxicologic Pathology"},{"key":"1960_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jchromb.2008.08.031","volume":"875","author":"S Van den Velde","year":"2008","unstructured":"Van den Velde, S., Nevens, F., Van Hee, P., van Steenberghe, D., & Quirynen, M. (2008). GC-MS analysis of breath odor compounds in liver patients. Journal of Chromatography B, 875, 344\u2013348. https:\/\/doi.org\/10.1016\/j.jchromb.2008.08.031.","journal-title":"Journal of Chromatography B"},{"issue":"4","key":"1960_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000478782","volume":"26","author":"M Wang","year":"2017","unstructured":"Wang, M., Xie, R., Jia, X., & Liu, R. (2017). Urinary volatile Organic Compounds as potential biomarkers in idiopathic membranous nephropathy. Medical Principles and Practice, 26(4), 375\u2013380. https:\/\/doi.org\/10.1159\/000478782.","journal-title":"Medical Principles and Practice"},{"issue":"3","key":"1960_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/tx7002454","volume":"21","author":"CE Wheelock","year":"2008","unstructured":"Wheelock, C. E., Forshed, J., Goto, S., Hammock, B. D., & Newman, J. W. (2008). Effects of pyridine exposure upon structural lipid metabolism in Swiss Webster mice. Chemical Research in Toxicology, 21(3), 583\u2013590. https:\/\/doi.org\/10.1021\/tx7002454.","journal-title":"Chemical Research in Toxicology"},{"key":"1960_CR33","doi-asserted-by":"publisher","first-page":"128381","DOI":"10.1016\/j.foodchem.2020.128381","volume":"6","author":"S Wu","year":"2021","unstructured":"Wu, S., Yang, J., Dong, H., Liu, Q., Li, X., Zeng, X., & Bai, W. (2021). Key aroma compounds of chinese dry-cured spanish mackerel (Scomberomorus niphonius) and their potential metabolic mechanisms. Food Chemistry, 6, 342:128381. https:\/\/doi.org\/10.1016\/j.foodchem.2020.128381.","journal-title":"Food Chemistry"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-022-01960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-022-01960-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-022-01960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:08:22Z","timestamp":1671689302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-022-01960-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s11306-022-01960-1","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"98"}}